OCUL
Ocular Therapeutix Inc
NASDAQ · Pharmaceuticals
$9.16
+0.25 (+2.81%)
Open$9.08
Previous Close$8.91
Day High$9.29
Day Low$8.95
52W High$16.44
52W Low$5.79
Volume—
Avg Volume5.20M
Market Cap1.95B
P/E Ratio—
EPS$-1.44
SectorPharmaceuticals
Analyst Ratings
Strong Buy
19 analysts
Price Target
+519.0% upside
Current
$9.16
$9.16
Target
$56.70
$56.70
$44.23
$56.70 avg
$95.28
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 85.77M | 75.54M | 415.51M |
| Net Income | -260,493,138 | -206,467,480 | 55.42M |
| Profit Margin | -303.7% | -288.5% | 13.3% |
| EBITDA | -263,774,069 | -220,682,840 | 92.87M |
| Free Cash Flow | — | — | 50.89M |
| Rev Growth | +13.6% | +13.6% | +9.7% |
| Debt/Equity | 0.22 | 0.22 | 0.37 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |